We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+24.29%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$782M
AUM Growth
+$121M
(+18%)
Cap. Flow
+$72.8K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
54.41%
Holding
77
New
6
Increased
14
Reduced
30
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KORU Medical Systems
KRMD
|
+$35.2M |
| 2 |
Tandem Diabetes Care
TNDM
|
+$8.16M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$6.75M |
| 4 |
Viatris
VTRS
|
+$6.41M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$6.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agios Pharmaceuticals
AGIO
|
+$10.8M |
| 2 |
AMRN
Amarin Corp
AMRN
|
+$8.75M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$6.04M |
| 4 |
Takeda Pharmaceutical
TAK
|
+$4.87M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$4.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 72.61% |
| 2 | Communication Services | 8.79% |
| 3 | Industrials | 1.3% |
| 4 | Energy | 0.94% |
| 5 | Financials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
51
DELISTED
Allergan plc
AGN
| $412K | 0.05% |
2,157
| – | – |
|
52
Merck
MRK
$322B
| $386K | 0.05% |
4,451
| – | – |
|
53
Health Catalyst
HCAT
$154M
| $385K | 0.05% |
11,100
| – | – |
|
54
AbbVie
ABBV
$443B
| $364K | 0.05% |
4,114
| – | – |
|
55
Novartis
NVS
$297B
| $335K | 0.04% |
3,535
| – | – |
|
56
Sanofi
SNY
$103B
| $334K | 0.04% |
6,650
| – | – |
|
57
Pfizer
PFE
$143B
| $332K | 0.04% |
8,926
| – | – |
|
58
Johnson & Johnson
JNJ
$618B
| $315K | 0.04% |
2,161
| – | – |
|
59
Baxter International
BAX
$13.5B
| $272K | 0.03% |
3,258
| – | – |
|
60
Amgen
AMGN
$208B
| $263K | 0.03% |
1,092
| – | – |
|
61
Steris
STE
$22.3B
| $251K | 0.03% |
1,649
| – | – |
|
|
HRC
62
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $241K | 0.03% |
2,121
| – | – |
|
63
Elevance Health
ELV
$81.5B
| $240K | 0.03% |
+795
| New | +$219K |
|
|
GRFS
64
Grifois
GRFS
$5.36B
| $237K | 0.03% |
10,166
| – | – |
|
65
Agilent Technologies
A
$39.1B
| $217K | 0.03% |
+2,548
| New | +$201K |
|
66
Smith & Nephew
SNN
$13.3B
| $215K | 0.03% |
4,472
| – | – |
|
67
Bio-Rad Laboratories Class A
BIO
$8.71B
| $203K | 0.03% |
+548
| New | +$193K |
|
68
UnitedHealth
UNH
$376B
| $203K | 0.03% |
+692
| New | +$181K |
|
|
DYNT
69
DELISTED
Dynatronics Corp
DYNT
| $105K | 0.01% |
25,209
+956
| +4% | +$3.94K |
|
|
70
Agios Pharmaceuticals
AGIO
$1.79B
| – | – |
-332,442
| Closed | -$10.8M |
|
71
Alkermes
ALKS
$8.22B
| – | – |
-123,107
| Closed | -$2.4M |
|
|
72
Takeda Pharmaceutical
TAK
$54.6B
| – | – |
-283,200
| Closed | -$4.87M |
|
73
10x Genomics
TXG
$6B
| – | – |
-5,000
| Closed | -$252K |
|
74
Q32 Bio
QTTB
$466M
| – | – |
-7,914
| Closed | -$2.58M |
|
|
KDNY
75
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-499,404
| Closed | -$2.65M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, First Light Asset Management held 77 positions worth $782M, up 18% from $662M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
First Light Asset Management's Q4 2019 filing shows 6 new, 14 increased, 30 reduced and 8 closed positions. Its largest new stake was KORU Medical Systems: 7,218,014 shares worth $47.1M. The largest sale was Agios Pharmaceuticals, an estimated $10.8M.
By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 68% a quarter earlier, followed by Communication Services and Industrials.
- First Light Asset Management's largest Q4 2019 buy was KORU Medical Systems: 7,218,014 shares worth $47.1M.
- First Light Asset Management added most to Tandem Diabetes Care in Q4 2019, an estimated $8.16M increase.
- First Light Asset Management's biggest Q4 2019 reduction was Amarin Corp, cutting an estimated $8.75M.
- First Light Asset Management fully exited Agios Pharmaceuticals in Q4 2019, selling an estimated $10.8M.
- First Light Asset Management's ten largest holdings make up 54% of its $782M portfolio in Q4 2019.
- First Light Asset Management opened 6 new positions and closed 8 in Q4 2019.
- First Light Asset Management's portfolio value rose 18% quarter-over-quarter to $782M.
Based on First Light Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.